PSAP-FAR1 Fusion FISH Probe
The PSAP-FAR1 Fusion FISH Probe is used to confirm a fusion of the PSAP and FAR1 genes. The fusion of the PSAP and FAR1 genes has been associated with Lung Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PSAP-FAR1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PSAP-FAR1-20-AQAQ | 20 (40 μL) | 200 μL |
|
PSAP Gene Summary
This gene encodes a highly conserved preproprotein that is proteolytically processed to generate four main cleavage products including saposins A, B, C, and D. Each domain of the precursor protein is approximately 80 amino acid residues long with nearly identical placement of cysteine residues and glycosylation sites. Saposins A-D localize primarily to the lysosomal compartment where they facilitate the catabolism of glycosphingolipids with short oligosaccharide groups. The precursor protein exists both as a secretory protein and as an integral membrane protein and has neurotrophic activities. Mutations in this gene have been associated with Gaucher disease and metachromatic leukodystrophy. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
Gene Name: Prosaposin
Chromosome: CHR10: 73576054 -73611082
Locus: 10q22.1
FAR1 Gene Summary
The protein encoded by this gene is required for the reduction of fatty acids to fatty alcohols, a process that is required for the synthesis of monoesters and ether lipids. NADPH is required as a cofactor in this reaction, and 16-18 carbon saturated and unsaturated fatty acids are the preferred substrate. This is a peroxisomal membrane protein, and studies suggest that the N-terminus contains a large catalytic domain located on the outside of the peroxisome, while the C-terminus is exposed to the matrix of the peroxisome. Studies indicate that the regulation of this protein is dependent on plasmalogen levels. Mutations in this gene have been associated with individuals affected by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity (PMID: 25439727). A pseudogene of this gene is located on chromosome 13. [provided by RefSeq, Jan 2015]
Gene Name: Fatty Acyl-CoA Reductase 1
Chromosome: CHR11: 13690205 -13753893
Locus: 11p15.3
Gene Diseases
The PSAP FAR1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Lung Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|